About
Thrombosis Therapies
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
55
By Phase
PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05970224Lead Sponsor
A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage
PHASE2Active, not recruiting
23 participants
Started: Nov 17, 2023 · Completed: Jul 31, 2027
NCT04653766Lead Sponsor
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ir-CPI in Healthy Male Subjects
PHASE1Completed
32 participants
Started: Sep 12, 2019 · Completed: Jan 4, 2023
Locations (1)
Headquarters
Gosselies, Belgium
Map
Loading map...